Titles and Roles
- Assistant Professor, Department of Radiation Oncology
- Emory University School of Medicine
- Research Program
- Cancer Prevention and Control
Shannon Kahn, MD, is a board certified radiation oncologist at Emory Saint Joseph's Hospital. She is skilled at Gamma Knife radiosurgery, partial breast irradiation and breast brachytherapy as well as stereotactic body radiotherapy in the treatment of early stage lung cancers. She has published and trained in the use of intensity modulated radiotherapy and its benefits in the minimization of treatment-related side effects.
Dr. Kahn is a clinical member of the Cancer Prevention and Control Research Program at Winship Cancer Institute. Her society memberships include the American Medical Association, the American Society of Therapeutic Radiology and Oncology and the American Society of Clinical Oncology.
Dr. Kahn received her MD at Emory University School of Medicine. She completed an internship in internal medicine and her residency in radiation oncology at Emory University. She attended the University of North Carolina at Chapel Hill where she earned her Bachelor of Science in Business Administration and a Master in Accountancy. She worked for Arthur Andersen as a certified public accountant and financial auditor prior to pursuing her medical career.
Dr. Kahn's research interests include examining newer technologies and treatment modalities in the treatment of breast cancer in order to minimize cosmetic changes while maximizing long-term tumor control.
Below is a listing of current federal grants for the above principal investigator.
Dr. Kahn has authored and co-authored numerous articles for both submissions to national research and healthcare meetings and to national and international peer-reviewed publications and book chapters. She has published on the use of radiotherapy in Hodgkin's and non-Hodgkin's lymphoma, the effectiveness and side-effect profile of radiotherapy in the treatment of prostate cancer, and the use of alternative treatment modalities for long-term treatment sequelae in head and neck cancers.
Publications Publication Date